Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry.
Arnould Louis, Balsat Elise, Hashimoto Yohei, White Andrew, Kong George, Dunn Hamish et al.
This study found the Xen 45 gel stent effectively lowers IOP in open-angle glaucoma over two years, but often requires reoperations, especially when combined with cataract surgery.